{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T09:46:30Z","timestamp":1777887990597,"version":"3.51.4"},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013170","name":"Ono Pharmaceutical Co Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013170","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jphs.2026.02.005","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T07:43:34Z","timestamp":1772264614000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of ONO-6950, a novel dual cysteinyl leukotriene 1 and 2 receptor antagonist, in guinea pig models of allergic rhinitis"],"prefix":"10.1016","volume":"161","author":[{"given":"Akihiro","family":"Kamiya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiko","family":"Sekioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masabumi","family":"Minami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jphs.2026.02.005_bib1","doi-asserted-by":"crossref","first-page":"527","DOI":"10.4168\/aair.2016.8.6.527","article-title":"Burden of respiratory disease in Korea: an observational study on allergic rhinitis, asthma, COPD, and rhinosinusitis","volume":"8","author":"Yoo","year":"2016","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jphs.2026.02.005_bib2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4168\/aair.2016.8.1.49","article-title":"Relationship between allergic rhinitis and mental health in the general Korean adult population","volume":"8","author":"Kim","year":"2016","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jphs.2026.02.005_bib3","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1517\/14728222.12.4.415","article-title":"Cysteinyl leukotriene receptor CysLT1 as a novel therapeutic target for allergic rhinitis","volume":"12","author":"Shirasaki","year":"2008","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.jphs.2026.02.005_bib4","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2147\/tcrm.2007.3.2.327","article-title":"Montelukast in the management of allergic rhinitis","volume":"3","author":"Jaime","year":"2007","journal-title":"Therapeut Clin Risk Manag"},{"key":"10.1016\/j.jphs.2026.02.005_bib5","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/21658","article-title":"Characterization of the human cysteinyl leukotriene CysLT1 receptor","volume":"399","author":"Lynch","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.jphs.2026.02.005_bib6","doi-asserted-by":"crossref","first-page":"30531","DOI":"10.1074\/jbc.M003490200","article-title":"Characterization of the human cysteinyl leukotriene 2 receptor","volume":"275","author":"Heise","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jphs.2026.02.005_bib7","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1046\/j.1365-2222.2002.01425.x","article-title":"Expression and localization of the cysteinyl leukotriene 1 receptor in human nasal mucosa","volume":"32","author":"Shirasaki","year":"2002","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jphs.2026.02.005_bib8","doi-asserted-by":"crossref","first-page":"8023","DOI":"10.1016\/S0021-9258(19)70597-3","article-title":"Inhibition of leukotriene C and leukotriene D biosynthesis","volume":"255","author":"Orning","year":"1980","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jphs.2026.02.005_bib9","doi-asserted-by":"crossref","first-page":"139","DOI":"10.5483\/BMBRep.2008.41.2.139","article-title":"Guinea pig cysteinyl leukotriene receptor 2 (gpCysLT2) mediates cell proliferation and intracellular calcium mobilization by LTC4 and LTD4","volume":"41","author":"Ito","year":"2008","journal-title":"BMB Rep"},{"key":"10.1016\/j.jphs.2026.02.005_bib10","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0022-3565(25)21552-X","article-title":"Pharmacological and biochemical evidence for metabolism of peptide leukotrienes by guinea-pig airway smooth muscle in vitro","volume":"231","author":"Snyder","year":"1984","journal-title":"J Pharmacol Exp Therapeut"},{"key":"10.1016\/j.jphs.2026.02.005_bib11","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/sj.bjp.0704180","article-title":"An alternative pathway for metabolism of leukotriene D4: effects on contractions to cysteinyl-leukotrienes in the guinea-pig trachea","volume":"133","author":"B\u00e4ck","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jphs.2026.02.005_bib12","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ejphar.2015.02.014","article-title":"Leukotriene C4 induces bronchoconstriction and airway vascular hyperpermeability via the cysteinyl leukotriene receptor 2 in S-hexyl glutathione-treated Guinea pigs","volume":"754","author":"Yonetomi","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jphs.2026.02.005_bib13","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ejphar.2015.08.041","article-title":"Effects of ONO-6950, a novel dual cysteinyl leukotriene 1 and 2 receptors antagonist, in a Guinea pig model of asthma","volume":"765","author":"Yonetomi","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jphs.2026.02.005_bib14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.plefa.2017.03.002","article-title":"A new CysLT1 and CysLT2 receptors-mediated anaphylaxis Guinea pig model","volume":"119","author":"Sekioka","year":"2017","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.jphs.2026.02.005_bib15","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1081-1206(10)61317-8","article-title":"The role of leukotrienes in allergic rhinitis","volume":"94","author":"Peters-Golden","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jphs.2026.02.005_bib16","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejphar.2016.11.036","article-title":"CysLT2 receptor activation is involved in LTC4-induced lung air-trapping in Guinea pigs","volume":"794","author":"Sekioka","year":"2017","journal-title":"Eur J Pharmacol"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861326000137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861326000137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:31:24Z","timestamp":1777609884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347861326000137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1347861326000137"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2026.02.005","relation":{},"ISSN":["1347-8613"],"issn-type":[{"value":"1347-8613","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of ONO-6950, a novel dual cysteinyl leukotriene 1 and 2 receptor antagonist, in guinea pig models of allergic rhinitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2026.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of Japanese Pharmacological Society.","name":"copyright","label":"Copyright"}]}}